NCT07753239

Brief Summary

The study aims to determine the effects of Oral Nutritional Supplement (ONS) added to usual care on body weight compared with usual care alone in community-dwelling adults aged 55 years and older who are at risk of malnutrition and have low muscle strength following acute care. Participants randomized to receive either ONS twice daily for 180 days plus usual care, or usual care alone. Usual care includes individualized dietary counseling and standardized physical activity advice provided. The study will assess body weight, nutritional status, muscle strength, physical function, dietary intake, and safety outcomes.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
304

participants targeted

Target at P75+ for not_applicable

Timeline
15mo left

Started Oct 2026

Geographic Reach
1 country

7 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Oct 2026Jan 2028

First Submitted

Initial submission to the registry

August 4, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 7, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2026

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2028

Last Updated

August 7, 2026

Status Verified

August 1, 2026

Enrollment Period

1.3 years

First QC Date

August 4, 2026

Last Update Submit

August 4, 2026

Conditions

Keywords

Oral nutritional supplementMalnutritionNutritional riskLow muscle strengthHandgrip strengthPost-dischargeOlder adultsBody weightPhysical functionSarcopenia

Outcome Measures

Primary Outcomes (1)

  • Change in body weight

    Measured in kg

    Day 0 to Day 180

Secondary Outcomes (13)

  • Change in body weight

    Study Day 30, Study Day 90 and Study Day 180

  • Body mass index (BMI)

    Study Day 30, Study Day 90 and Study Day 180

  • Calf circumference

    Study Day 30, Study Day 90 and Study Day 180

  • Mid-upper arm circumference (MUAC)

    Study Day 30, Study Day 90 and Study Day 180

  • Body composition

    Study Day 30, Study Day 90 and Study Day 180

  • +8 more secondary outcomes

Study Arms (2)

Feeding: Intervention

EXPERIMENTAL
Dietary Supplement: ONSOther: Standard of Care (SOC)

Feeding: None

OTHER
Other: Standard of Care (SOC)

Interventions

ONSDIETARY_SUPPLEMENT

230 mL per serving, twice daily

Feeding: Intervention

Dietary counseling and physical activity advice

Feeding: InterventionFeeding: None

Eligibility Criteria

Age55 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At risk of malnutrition.
  • At the point of hospital discharge, the admission was for an acute medical illness.
  • Has low maximum handgrip strength.
  • Estimated life expectancy of more than 12 months.
  • Community ambulant.
  • No other chronic disease.
  • Able to communicate and follow instructions.
  • Able to consume food and beverages orally.
  • Willing to refrain from taking non-study oral nutritional supplements over the course of the study.
  • Able and willing to follow study procedures.

You may not qualify if:

  • Index hospitalization admission was for a surgical procedure or a stroke/myocardial infarction.
  • Diagnosed with type 1 or type 2 diabetes.
  • Has an active infectious disease.
  • Diagnosed with severe gastrointestinal disorders.
  • With severe or unstable congestive heart failure.
  • With chronic kidney disease stage 2 or higher, end-stage organ failure, or other pre-terminal condition.
  • Has an active malignancy within the past five years or currently receiving treatment for malignancy.
  • Has a severe or unstable musculoskeletal or neuromuscular disorder.
  • Unable to perform a valid handgrip strength assessment.
  • Any condition that makes the participant unsuitable for the study.
  • Currently enrolled in another clinical study.
  • Has an eating disorder, alcoholism or substance abuse.
  • Has dementia, delirium, or a significant neurological or psychiatric disorder.
  • Known allergy or intolerance to any ingredients of the study product.
  • Continuous use of ONS for 14 days prior to the baseline visit.
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

King Chulalongkorn Memorial Hospital

Bangkok, Thailand

Location

Phramongkutklao Hospital

Bangkok, Thailand

Location

Siriraj Hospital

Bangkok, Thailand

Location

Vajira Hospital

Bangkok, Thailand

Location

Maharaj Nakorn Chiang Mai Hospital

Chiang Mai, Thailand

Location

Songklanagarind Hospital

Hat Yai, Thailand

Location

Naresuan University Hospital

Phitsanulok, Thailand

Location

MeSH Terms

Conditions

MalnutritionBody WeightSarcopenia

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, Anatomical

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Mandy Yen Ling Ow, Ph.D.

    Abbott Nutrition

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Prospective, multicenter, randomized, controlled, open-label, parallel-design study.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 4, 2026

First Posted

August 7, 2026

Study Start

October 1, 2026

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

January 1, 2028

Last Updated

August 7, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations